Ipamorelin Phase 2 Postoperative Ileus Trial Results
Phase 2 double-blind RCT found ipamorelin well tolerated in 117 bowel-surgery patients; median time to meal tolerance trended 7 hours shorter than placebo.
Phase 2 double-blind RCT found ipamorelin well tolerated in 117 bowel-surgery patients; median time to meal tolerance trended 7 hours shorter than placebo.